Ligand · EP9
EP9 · N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2S,3S)-3-hydroxy-1-(4-hydroxyphenyl)-4-oxobutan-2-yl]-L-leucinamide
EP9, N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2S,3S)-3-hydroxy-1-(4-hydroxyphenyl)-4-oxobutan-2-yl]-L-leucinamide (C30 H41 N3 O7, 555.7 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with…
- Component
- EP9
- Formula
- C30 H41 N3 O7
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
EP9 in 2 structures; the first of them:
- 3OKJ · Alpha-keto-aldehyde binding mechanism reveals a novel lead structure motif for proteasome… · EP9 K300 · binds THR1, ARG19, ALA20, THR21, ALA22, GLY23, ALA27, VAL31 and 12 more
- 3OKJ · Alpha-keto-aldehyde binding mechanism reveals a novel lead structure motif for proteasome… · EP9 K300 · binds THR1, ARG19, ALA20, THR21, ALA22, GLY23, ALA27, VAL31 and 12 more
Residues it binds most
ALA 4, GLY 4, SER 4, THR 4, ARG 4, ASP 4, GLN 4, GLU 4, LYS 4, MET 4 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.